Content Type: Research Publications

Biologic Patent Challenges Under the America Invents Act

March 6, 2026

Administrative Action on Drug Pricing: Lessons and Opportunities for the Center for Medicare and Medicaid Innovation

March 6, 2026

Delivery Device Patents on GLP-1 Receptor Agonists

March 6, 2026

The Constitutionality of Medicare Drug-Price Negotiation Under the Takings Clause

March 6, 2026

Inequitable Conduct and Invalidation of Patents Related to Food and Drug Administration-Regulated Products

March 6, 2026

Ancillary Product Patents to Extend Biologic Patent Life

March 6, 2026

Building Public Trust in Scientific Decision Making Through Expert Advisory Committees: Lessons From the FDA

March 6, 2026

Potential Medicare and Medicaid Savings on Anti-CD20 Therapy for Multiple Sclerosis

March 6, 2026

Physicians’ Perspectives on FDA Regulation of Drugs and Medical Devices: A National Survey

March 6, 2026

CRISPR-Phage Antibacterials to Address the Antibiotic Resistance Crisis: Scientific, Economic, and Regulatory Considerations

March 6, 2026

Cost of Exempting Sole Orphan Drugs From Medicare Negotiation

March 6, 2026

Biologic Patent Thickets and Terminal Disclaimers

March 6, 2026